MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Cerebral metabolic network in PLA2G6-associated parkinsonism

XY. Zhou, J. Wang, C. Chen, FT. Liu, CT. Zuo, JJ. Wu, YM. Sun, J. Wang (Shanghai, China)

Meeting: 2024 International Congress

Abstract Number: 1038

Keywords: Parkinsonism, Positron emission tomography(PET)

Category: Parkinson's Disease: Neuroimaging

Objective: To characterize the cerebral metabolic network in PLA2G6-associated parkinsonism (PLA2G6-P).

Background: PLA2G6-associated neurodegeneration is known as a continuum of phenotypes. Patients with late-onset PLA2G6-associated neurodegeneration commonly manifest with complex parkinsonism. Patients with PLA2G6-associated parkinsonism can combine with dystonia, ataxia, cognitive and psychiatric impairment, and pyramidal signs, leading to misdiagnosis and delayed diagnosis. The pathophysiological processes contributing to the development of PLA2G6-P remain largely elusive.

Method: 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) was performed in 19 patients with PLA2G6-P and 21 healthy control subjects to identify and validate the disease-related pattern. The derivation cohort (Cohort A) comprised 10 randomly selected healthy controls (32.0±5.1 years old) and 10 patients with PLA2G6-P (31.5±4.3 years old), while the testing cohort (Cohort B) comprised the remaining 11 healthy controls (31.1±4.5 years old) and 11 PLA2G6-P patients (31.0±2.4 years old) including 9 remaining PLA2G6-P patients and two PLA2G6-P patients from the derivation cohort who received PET scans again during follow-up.

Results: We identified a significant PLA2G6-P related pattern (PLPRP) from the derivation cohort (Cohort A), which was characterized by increased metabolism in putamen, thalamus, brainstem, cerebellum, precuneus, paracentral and postcentral gyrus, anterior and middle cingulate, and supplementary motor area, and with decreased metabolism in occipital lobe, lingual gyrus (Figure 1A). The network expression of PLPRP was significantly elevated (p < 0.0001) in PLA2G6-P compared to controls in the derivation cohort (Cohort A) and was validated in the testing cohort (Cohort B) (p< 0.0001) (Figure 1B). Compared to the Parkinson’s disease related pattern (PDRP), the PLA2G6-P was characterized by relatively increased metabolic activity in the pons, thalamus, brainstem, putamen, cingulate, supplementary motor area, frontal and relatively decreased in occipital and cerebellum (p < 0.001, uncorrected).

Conclusion: Abnormal brain activity among the motor cortex, basal ganglia, thalamus, brainstem and cerebellum was found in PLA2G6-P. The characteristic pattern represents a promising step in understanding the neural circuit of PLA2G6-associated parkinsonism, and can offer important hints to the clinical diagnosis.

Figure 1

Figure 1

To cite this abstract in AMA style:

XY. Zhou, J. Wang, C. Chen, FT. Liu, CT. Zuo, JJ. Wu, YM. Sun, J. Wang. Cerebral metabolic network in PLA2G6-associated parkinsonism [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/cerebral-metabolic-network-in-pla2g6-associated-parkinsonism/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/cerebral-metabolic-network-in-pla2g6-associated-parkinsonism/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley